Carvedilol
- Product NDC
- 43547-254
- 11-digit product format
- 435470254
- Labeler code
- 43547
- Product ID
- 43547-254_9db9f3d1-f2f8-456d-b4ff-0de943ccb448
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carvedilol
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Solco Healthcare US LLC
- Application
- ANDA078384
- Marketing category
- ANDA
- Marketing start
- 2010-06-01
- Marketing end
- 2020-08-01
- Substance
- CARVEDILOL
- Active strength
- 3 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43547-254-10 | 2020-03-04 | C162847 | 48780-1 | 9d75b9d0-1f5d-f424-e053-dadaa90a57ce | 2ba6d893-ae2a-4535-b904-667d206f93af |
| 43547-254-11 | 2020-03-04 | C162847 | 48780-1 | 9d75b9d0-1f5d-f424-e053-dadaa90a57ce | 2ba6d893-ae2a-4535-b904-667d206f93af |
| 43547-254-50 | 2020-03-04 | C162847 | 48780-1 | 9d75b9d0-1f5d-f424-e053-dadaa90a57ce | 2ba6d893-ae2a-4535-b904-667d206f93af |
| 43547-254-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f5d-f424-e053-dadaa90a57ce | 2ba6d893-ae2a-4535-b904-667d206f93af |
| 43547-254-11 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f5d-f424-e053-dadaa90a57ce | 2ba6d893-ae2a-4535-b904-667d206f93af |
| 43547-254-50 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1f5d-f424-e053-dadaa90a57ce | 2ba6d893-ae2a-4535-b904-667d206f93af |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43547-254-10 | EA - Each | 43547-254 | 1631bb34-4d7f-4e51-b932-9a7986660ab4 | 1 | 2012-07-24 |
| 43547-254-50 | EA - Each | 43547-254 | 9f62c547-f28b-4e1d-9275-893022a514e1 | 1 | 2012-07-24 |